LGALS3 and pulmonary arterial hypertension: While this may be associated with greater systemic fibrosis and inflammation seen in HFpEF populations, no correlations between galectin-3 levels and any measured hemodynamic endpoints were found in PH-HFpEF or PAH patients in this study (48).